CDXC logo

Niagen Bioscience, Inc. (CDXC) Operating Margin

Annual Operating Margin:

7.76%+14.46%(+215.82%)
December 31, 2024

Summary

  • As of today, CDXC annual operating profit margin is 7.76%, with the most recent change of +14.46% (+215.82%) on December 31, 2024.
  • During the last 3 years, CDXC annual operating margin has risen by +47.90% (+119.33%).

Performance

CDXC Operating Margin Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Range

Earnings dates

OtherCDXCprofitability metrics

Quarterly Operating Margin:

15.66%-8.76%(-35.87%)
March 31, 2025

Summary

  • As of today, CDXC quarterly operating profit margin is 15.66%, with the most recent change of -8.76% (-35.87%) on March 31, 2025.
  • Over the past year, CDXC quarterly operating margin has increased by +18.96% (+574.55%).

Performance

CDXC Quarterly Operating Margin Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Range

Earnings dates

OtherCDXCprofitability metrics

Operating Margin Formula

Operating Profit Margin =  Operating Profit
Revenue
✕ 100%

CDXC Operating Margin Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1Y1 Year+215.8%+574.5%
3Y3 Years+119.3%+135.0%
5Y5 Years+111.5%+138.1%

CDXC Operating Margin Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs Low
3Y3-Yearat high+119.3%-35.9%+187.2%
5Y5-Yearat high+111.5%-35.9%+130.7%
All-TimeAll-Timeat high+107.4%-35.9%+103.2%

CDXC Operating Margin History

DateAnnualQuarterly
Mar 2025
-
15.66%(-35.9%)
Dec 2024
7.76%(+215.8%)
24.42%(+290.1%)
Sep 2024
-
6.26%(+654.0%)
Jun 2024
-
-1.13%(+65.8%)
Mar 2024
-
-3.30%(-317.7%)
Dec 2023
-6.70%(+74.1%)
-0.79%(+86.6%)
Sep 2023
-
-5.88%(+48.4%)
Jun 2023
-
-11.40%(-30.6%)
Mar 2023
-
-8.73%(-26.9%)
Dec 2022
-25.85%(+35.6%)
-6.88%(+61.7%)
Sep 2022
-
-17.96%(+52.9%)
Jun 2022
-
-38.17%(+14.8%)
Mar 2022
-
-44.80%(-49.7%)
Dec 2021
-40.14%(-19.8%)
-29.93%(+41.4%)
Sep 2021
-
-51.08%(-62.8%)
Jun 2021
-
-31.38%(+37.4%)
Mar 2021
-
-50.14%(-27.4%)
Dec 2020
-33.50%(+50.5%)
-39.37%(-33.1%)
Sep 2020
-
-29.59%(-22.7%)
Jun 2020
-
-24.12%(+41.3%)
Mar 2020
-
-41.06%(+39.3%)
Dec 2019
-67.62%(+35.7%)
-67.69%(-18.4%)
Sep 2019
-
-57.15%(+11.6%)
Jun 2019
-
-64.68%(+22.4%)
Mar 2019
-
-83.32%(+8.3%)
Dec 2018
-105.12%(-36.1%)
-90.88%(+14.2%)
Sep 2018
-
-105.86%(-4.1%)
Jun 2018
-
-101.72%(+20.5%)
Mar 2018
-
-127.90%(-9.7%)
Dec 2017
-77.25%(-476.1%)
-116.56%(-123.3%)
Sep 2017
-
-52.20%(+16.9%)
Jun 2017
-
-62.83%(-19.4%)
Mar 2017
-
-52.64%(-7.9%)
Dec 2016
-13.41%
-48.78%(-107.8%)
DateAnnualQuarterly
Sep 2016
-
-23.47%(-658.8%)
Jun 2016
-
4.20%(-32.1%)
Mar 2016
-
6.19%(+101.3%)
Dec 2015
-11.55%(+65.9%)
-490.20%(>-9900.0%)
Sep 2015
-
2.82%(+193.4%)
Jun 2015
-
-3.02%(+82.5%)
Mar 2015
-
-17.22%(+32.3%)
Dec 2014
-33.86%(+20.8%)
-25.44%(-62.7%)
Sep 2014
-
-15.64%(+63.3%)
Jun 2014
-
-42.57%(+28.0%)
Mar 2014
-
-59.11%(-101.8%)
Dec 2013
-42.73%(+57.4%)
-29.29%(+34.1%)
Sep 2013
-
-44.46%(-18.8%)
Jun 2013
-
-37.43%(+38.3%)
Mar 2013
-
-60.67%(-26.3%)
Dec 2012
-100.22%(-3.4%)
-48.05%(-13.9%)
Sep 2012
-
-42.17%(+71.8%)
Jun 2012
-
-149.31%(+39.8%)
Mar 2012
-
-247.89%(-80.4%)
Dec 2011
-96.94%(-263.6%)
-137.39%(-4.7%)
Sep 2011
-
-131.20%(-38.6%)
Jun 2011
-
-94.68%(-109.4%)
Mar 2011
-
-45.21%(-3.3%)
Dec 2010
-26.66%(-72.6%)
-43.77%(+21.7%)
Sep 2010
-
-55.92%(-287.8%)
Jun 2010
-
-14.42%(-810.3%)
Mar 2010
-
2.03%(+128.2%)
Dec 2009
-15.45%(+66.3%)
-7.20%(+40.6%)
Sep 2009
-
-12.12%(+43.3%)
Jun 2009
-
-21.37%(+3.4%)
Mar 2009
-
-22.13%(+58.2%)
Dec 2008
-45.80%
-52.97%(+18.9%)
Sep 2008
-
-65.33%(-25.1%)
Jun 2008
-
-52.21%

FAQ

  • What is Niagen Bioscience, Inc. annual operating profit margin?
  • What is the all-time high annual operating margin for Niagen Bioscience, Inc.?
  • What is Niagen Bioscience, Inc. annual operating margin year-on-year change?
  • What is Niagen Bioscience, Inc. quarterly operating profit margin?
  • What is the all-time high quarterly operating margin for Niagen Bioscience, Inc.?
  • What is Niagen Bioscience, Inc. quarterly operating margin year-on-year change?

What is Niagen Bioscience, Inc. annual operating profit margin?

The current annual operating margin of CDXC is 7.76%

What is the all-time high annual operating margin for Niagen Bioscience, Inc.?

Niagen Bioscience, Inc. all-time high annual operating profit margin is 7.76%

What is Niagen Bioscience, Inc. annual operating margin year-on-year change?

Over the past year, CDXC annual operating profit margin has changed by +14.46% (+215.82%)

What is Niagen Bioscience, Inc. quarterly operating profit margin?

The current quarterly operating margin of CDXC is 15.66%

What is the all-time high quarterly operating margin for Niagen Bioscience, Inc.?

Niagen Bioscience, Inc. all-time high quarterly operating profit margin is 24.42%

What is Niagen Bioscience, Inc. quarterly operating margin year-on-year change?

Over the past year, CDXC quarterly operating profit margin has changed by +18.96% (+574.55%)
On this page